Luigi Zecca

Luigi Zecca

Auto-generated profile, based on publicly available information

Luigi Zecca

Institute of Biomedical Technologies National Research Council of Italy Via Cervi 93, Segrate Milan 20054 Italy

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
MBMichelle L. Block
Michelle L. Block
LZLuigi Zecca
Luigi Zecca
JHJau-shyong Hong
Jau-shyong Hong

1 October 2014 in The Lancet Neurology
Verified
Journal Article
Closed access
Roberta J. WardRoberta J. Ward
Roberta J. Ward
FZFabio A. Zucca
Fabio A. Zucca
JDJeff H Duyn
Jeff H Duyn
RCRobert R Crichton
Robert R Crichton
LZLuigi Zecca
Luigi Zecca

1 November 2004 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
PDF file
LZLuigi Zecca
Luigi Zecca
MYMoussa B. H. Youdim
Moussa B. H. Youdim
PRPeter Riederer
Peter Riederer
JCJames R. Connor
James R. Connor
RCRobert R. Crichton
Robert R. Crichton

1 August 2017 in Progress in Neurobiology
Verified
Journal Article
Closed access
FZFabio A. Zucca
Fabio A. Zucca
JSJuan Segura-Aguilar
Juan Segura-Aguilar
EFEmanuele Ferrari
Emanuele Ferrari
PMPatricia Muñoz
Patricia Muñoz
IPIrmgard Blanca Paris
Irmgard Blanca Paris
LZLuigi Zecca
Luigi Zecca

1 July 2000 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AFAnnalisa Frattini
Annalisa Frattini
POPaul J. Orchard
Paul J. Orchard
CSCristina Sobacchi
Cristina Sobacchi
SGSilvia Giliani
Silvia Giliani
MAMario Abinun
Mario Abinun
AVAnna Villa
Anna Villa

21 June 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
LZLuigi Zecca
Luigi Zecca
ASAntonella Stroppolo
Antonella Stroppolo
AGAlberto Gatti
Alberto Gatti
DTDavide Tampellini
Davide Tampellini
MTMarco Toscani
Marco Toscani
FZFabio A. Zucca
Fabio A. Zucca
In this study, a comparative analysis of metal-related neuronal vulnerability was performed in two brainstem nuclei, the locus coeruleus (LC) and substantia nigra (SN), known targets of the etiological noxae in Parkinson's disease and related disorders. LC and SN pars compacta neurons both degenerate in Parkinson's disease and other Parkinsonisms; however, LC neurons are comparatively less affected and with a variable degree of involvement. In this study, iron, copper, and their major molecular forms like ferritins, ceruloplasmin, neuromelanin (NM), manganese-superoxide dismutase (SOD), and copper/zinc-SOD were measured in LC and SN of normal subjects at different ages. Iron content in LC was much lower than that in SN, and the ratio heavy-chain ferritin/iron in LC was higher than in the SN. The NM concentration was similar in LC and SN, but the iron content in NM of LC was much lower than SN. In both regions, heavy- and light-chain ferritins were present only in glia and were not detectable in neurons. These data suggest that in LC neurons, the iron mobilization and toxicity is lower than that in SN and is efficiently buffered by NM. The bigger damage occurring in SN could be related to the higher content of iron. Ferritins accomplish the same function of buffering iron in glial cells. Ceruloplasmin levels were similar in LC and SN, but copper was higher in LC. However, the copper content in NM of LC was higher than that of SN, indicating a higher copper mobilization in LC neurons. Manganese-SOD and copper/zinc-SOD had similar age trend in LC and SN. These results may explain at least one of the reasons underlying lower vulnerability of LC compared to SN in Parkinsonian syndromes.